Journal of translational medicine 2018 02 1516(1) 30 doi 10.1186/s12967-018-1404-z
The presence of B cells in early stage non-small cell lung cancer (NSCLC) is associated with longer survival, however, the role these cells play in the generation and maintenance of anti-tumor immunity is unclear. B cells differentiate into a variety of subsets with differing characteristics and functions. To date, there is limited information on the specific B cell subsets found within NSCLC. To better understand the composition of the B cell populations found in NSCLC we have begun characterizing B cells in lung tumors and have detected a population of B cells that are CD79ACD27IgD. These CD27IgD(double-negative) B cells have previously been characterized as unconventional memory B cells and have been detected in some autoimmune diseases and in the elderly population but have not been detected previously in tumor tissue.
A total of 15 fresh untreated NSCLC tumors and 15 matched adjacent lung control tissues were dissociated and analyzed by intracellular flow cytometry to detect the B cell-related markers CD79A, CD27 and IgD. All CD79AB cells subsets were classified as either naïve (CD27IgD), affinity-matured (CD27IgD), early memory/germinal center cells (CD27IgD) or double-negative B cells (CD27IgD). Association of double-negative B cells with clinical data including gender, age, smoking status, tumor diagnosis and pathologic differentiation status were also examined using the logistic regression analysis for age and student’s t-test for all other variables. Associations with other B cell subpopulations were examined using Spearman’s rank correlation.
We observed that double-negative B cells were frequently abundant in lung tumors compared to normal adjacent controls (13 out of 15 cases), and in some cases made up a substantial proportion of the total B cell compartment. The presence of double-negative cells was also found to be inversely related to the presence of affinity-matured B cells within the tumor, Spearman’s coefficient of – 0.76.
This study is the first to observe the presence of CD27IgDdouble-negative B cells in human NSCLC and that this population is inversely correlated with traditional affinity-matured B cell populations.